Vienna, Austria (ots/PRNewswire) - sanofi pasteur, [NYSE: SNY] the vaccines business of the sanofi-aventis Group, today announced that its H5N1 pre-pandemic vaccine induces antibodies that neutralize additional H5N1 circulating virus not included in the original vaccine formulation. These data, presented at the 2nd International Conference on Influenza Vaccines ...
Fukuoka, Japan (ots/PRNewswire) - - Therapy May Benefit Hypertensive Patients With Additional Risk Factors in Populations Across Asia and Latin America Single-pill amlodipine besylate/atorvastatin calcium (Caduet(R)) may reduce the 10-year risk of having a cardiovascular (CV) event - as determined by the ...
Vancouver, Canada (ots/PRNewswire) - Ross River Minerals Inc. (TSX-V: RRM) (the "Company") is pleased to announce that it has resumed exploration on its 20,231 hectare El Pulpo gold-silver-copper property located in Sinaloa State, Mexico. The Company will initially focus on the newly discovered Jutamo copper-gold porphyry prospect (see press release dated July 7, 2006) and the north-trending Papaya gold-silver vein system. The Company has identified three major gold- ...
Bristol-Myers Squibb Medical Imaging
N. Billerica, Massachusetts (ots/PRNewswire) - Bristol-Myers Squibb Medical Imaging announced today that the European Commission has granted marketing authorisation for LUMINITY(TM), an ultrasound contrast agent, for use in patients with suboptimal echocardiograms who have suspected or established ...
Bristol-Myers Squibb Medical Imaging
N. Billerica, Massachusetts (ots/PRNewswire) - Bristol-Myers Squibb Medical Imaging announced today that the European Commission has granted marketing authorisation for LUMINITY(TM), an ultrasound contrast agent, for use in patients with suboptimal echocardiograms who have suspected or established ...
u-blox announces dual GPS and Galileo chip featuring acquisition time of under 1 second Thalwil (ots) u-blox AG, the leading Swiss provider of innovative GPS receiver technology, today announced the u-blox 5 family of GPS and Galileo-ready single chips and chipsets featuring an acquisition performance of under 1 second. The new chips also feature SuperSense® -160 ...
Lyon, France (ots/PRNewswire) - Sanofi pasteur, the vaccines business of the sanofi-aventis Group, has within the framework of FLUPAN, a collaborative research project funded by the European Commission, generated the first clinical trial lot of a new generation of H7N1 pandemic vaccine. This trial will broaden ...
Amsterdam (ots/PRNewswire) - - Revenue[1] Up 2% at Constant Exchange Rates (-1% at Current Exchange Rates) - Operating Margin1 at 3.7%, Reflecting Fierce Competition in Mobile Communication - Cash and Cash Equivalents at USD 478 Million - Continuing Challenging Industry Environment - Synergies and Long-Term Objectives Confirmed Gemalto (Euronext NL0000400653 - GTO), a leader in digital security, today announced its results for the half year ended ...
Sanofi-aventis; Bristol-Myers Squibb
Paris (ots/PRNewswire) - - PLAVIX indication expanded to include patients with any acute coronary syndromes (ACS) - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the European Commission has granted a new indication for the antiplatelet ...
Barcelona (ots/PRNewswire) - - Results of the PCI-ExTRACT Sub-Study Results of the PCI-ExTRACT-TIMI 25 study announced today at the World Congress of Cardiology-European Society of Cardiology 2006 in Barcelona, showed that among patients with ST-segment elevation myocardial infarction (STEMI) who ...
Barcelona, Spain (ots/PRNewswire) - - Coversyl(R) in PEP-CHF Trial, is the First Agent to Demonstrate Clinical Benefits in Elderly Heart Failure Patients With Diastolic Dysfunction The ACE inhibitor Coversyl(R) (perindopril) provides a number of clinical benefits to elderly people with chronic heart failure according to the results of a study presented at ...
Toronto (ots/PRNewswire) - - TMC125 a Next-Generation NNRTI Tibotec Pharmaceuticals Ltd. presented 48 week efficacy and safety data on TMC125, a next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), at the 16th International AIDS conference (IAC), AIDS 2006, in Toronto, Canada this week. TMC125 is currently being investigated in phase 3 trials (DUET 1 and 2) in treatment-experienced adult ...
Macclesfield, England (ots/PRNewswire) - - International Panel of Breast Cancer Specialists Agree: 'With Successful Adjuvant Therapy, Early Breast Cancer is Potentially a Curable Condition.' - ATTN: Health Professional Press - For International Journalists - Not for US Media Today, leading breast cancer experts advised unequivocally that 5 years' ...
Heilbronn, Germany (ots/PRNewswire) - - Best Trade-off of Large Bandwidth and High Selectivity Atmel(R) Corporation (Nasdaq: ATML), a global leader in the development and fabrication of advanced semiconductor solutions, announced today the availability of the new ATA5745 and ATA5746 UHF ASK/FSK receiver ICs, extending Atmel's broad existing portfolio ...
San Diego (ots/PRNewswire) - Revenues US$1.95 Billion, Diluted EPS US$0.37 Pro Forma Revenues US$1.95 Billion, Diluted EPS US$0.42 Fourth Consecutive Quarter of Record Revenues and Chip Shipments; Financial Guidance Increased for Fiscal 2006 QUALCOMM Incorporated (Nasdaq: QCOM) today announced results for the third fiscal quarter ended June 25, 2006. Total ...
Lund, Sweden (ots/PRNewswire) - - New Patient Data in COPD Brings Valuable Insight to the Consequences of Exacerbations on Patients' Lives, Demonstrating a Strong Psychological Impairment New data from a multinational, interview-based patient study, published today in the medical journal CHEST, shed light ...
Bangalore, India (ots/PRNewswire) - - Company's First Integrated Development Center (IDC) Opens in Bangalore as Part of Strategic Development of its Global Clinical Studies Program GE Healthcare, a division of the General Electric Company (NYSE:GE) today announced the opening of its first ...
Birmingham, England (ots/PRNewswire) - For Non-US Journalists Only - For Severe COPD Patients Treated With Budesonide Added to Either Formoterol (Symbicort, AstraZeneca) and/or a Short Acting Bronchodilator, There is a Reduced Risk of Mortality Compared to Patients Treated With Only Formoterol and/or ...
Shire Pharmaceuticals Group Plc
Basingstoke, England (ots/PRNewswire) - - First Human Cell Line-Derived Erythropoietin Research Reported BASINGSTOKE, England, June 16 /PRNewswire/ -- - Abstract Numbers: 562 and 576 Effective treatment of anaemia in patients suffering from chronic kidney disease (CKD)(x) is possible with the first erythropoietin product produced in a human cell ...
Mental Health Research Institute and Monash University of Victoria, Australia
Victoria, Australia (ots/PRNewswire) - A new study published by physicians from the Mental Health Research Institute and Monash University of Victoria, Australia, showed that all atypical antipsychotics studied were equally efficacious when used at optimal doses as primary medication for inpatients with acute ...
San Diego (ots/PRNewswire) - QUALCOMM Incorporated (Nasdaq: QCOM) today updated its financial guidance for the third fiscal quarter ending June 25, 2006. The following statements are forward looking and actual results may differ materially. Please see "Note Regarding Forward-Looking Statements" at the end of this news release for a description of certain ...
Toronto, Canada (ots/PRNewswire) - - The Increase of OPG Expression Explains the Uncoupling Effect of Protelos(R) on Bone Metabolism Exciting new data presented at the World Congress on Osteoporosis further the understanding of the unique dual mode of action of the anti-osteoporotic agent Protelos(R) ...
San Jose, California (ots/PRNewswire) - - 5.0V Core CMOS, 17.0V and 40.0V LDMOS Transistors Atmel(R) Corporation (Nasdaq: ATML), a global leader in the development and fabrication of advanced semiconductor solutions, announced today the release of its AT35700 high-voltage process technology with double-poly, high-density EEPROM for IC foundry customers. This ...
San Diego, California (ots/PRNewswire) - - For Accredited International Healthcare Journalists Only - Management of Exacerbations `Crucial' to Reduce COPD Mortality Survey results from the `Time to Live' report, presented today at the American Thoracic Society International Congress, show over two thirds of primary care physicians (66%) fear COPD will be ...
- EBITDA DOUBLES TO 183.6 MILLION - GROUP SALES RISE TO 798.5 MILLION, 190 MILLION ABOVE PRIOR-YEAR - EARNINGS PER SHARE CLIMB STRONGLY TO 1.49 - FOR 2006, SALES GROWTH ABOVE 10 PERCENT AND EBITDA BETWEEN 640 MILLION AND 680 MILLION EXPECTED ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Wacker Chemie AG reports a year-on-year sales ...
San Diego (ots/PRNewswire) - QUALCOMM Incorporated (Nasdaq: QCOM) today updated its financial guidance for the third fiscal quarter ending June 25, 2006. QUALCOMM is hosting its analyst meeting for institutional investors and equity analysts on May 4, 2006 in New York, NY. The meeting will be simulcast on the Company's website at www.qualcomm.com. Executive ...
Vienna, Austria (ots/PRNewswire) - Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week clinical trial results demonstrating that entecavir maintains more viral load suppression compared to lamivudine in nucleoside-naive, chronic hepatitis B e-antigen-negative (HBeAg-) patients. Data ...
San Diego (ots/PRNewswire) - - Revenues US$1.83 Billion, Diluted EPS US$0.34 SAN DIEGO, April 19 /PRNewswire/ -- - Pro Forma Revenues US$1.83 Billion, Diluted EPS US$0.41 SAN DIEGO, April 19 /PRNewswire/ -- - Third Consecutive Quarter of Record Revenues and Chip Shipments; Financial Guidance Increased for Fiscal 2006 QUALCOMM Incorporated (Nasdaq: QCOM) today announced results for the second fiscal ...
Lund, Sweden (ots/PRNewswire) - - For Accredited International Medical Media Only AstraZeneca (LSE: AZN , NYSE: AZN) has today welcomed preliminary results from the TORCH (TOwards a Revolution in COPD Health) study1, suggesting combination therapies containing an inhaled corticosteroid (ICS) and long-acting beta 2 agonist (LABA) have the potential to show mortality benefits for COPD patients. The ...
Vienna, Austria (ots/PRNewswire) - - New Data Demonstrate "Unique", Five Year Anti-Osteoporotic Efficacy Against Both Vertebral and Non-Vertebral Fractures New five year data presented at the 6th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 6) meeting today show that the new osteoporosis treatment Protelos(R) ...